Clinical trials: Human T-lymphotropic Virus 1
Adult T-cell Leukemia, Lymphoma
A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)
To test the superiority of VCAP-AMP-VECP regimen over biweekly-CHOP in aggressive ATLL in terms of survival benefit.
- Trial name
- NCT00145002
- Testing
- VCAP-AMP-VECP with G-CSF and intrathecal prophylaxis, biweekly-CHOP with G-CSF and intrathecal prophylaxis
- Where
- Japan
- Volunteers
- 130 people
- Sponsor
- Japan Clinical Oncology Group
HTLV-1 Infection, HTLV I Associated Myelopathies
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
This phase 2b, open-label, randomized controlled trial evaluates the efficacy and safety of dolutegravir (DTG) alone versus dolutegravir combined with tenofovir disoproxil fumarate (TDF) in individuals with HTLV-1 infection and…
- Conditions
- HTLV-1 Infection, HTLV I Associated Myelopathies, HTLV I Associated T Cell Leukemia Lymphoma, Neuritis
- Trial name
- DOT-H (NCT07555431)
- Testing
- Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG)
- Where
- Brazil
- Volunteers
- 146 people
- Sponsor
- Carlos Brites
HTLV-I Infections
Electromiography Study in the Respiratory Muscle Training in Human Lymphotropic Virus Type 1
The main objective of the research will be to analyze, through surface electromyography, the impact of inspiratory muscle training before a supervised home training protocol in patients with human T-cell lymphotropic virus type 1…
- Trial name
- NCT03829709
- Testing
- Rehabilitation
- Where
- Brazil
- Volunteers
- 20 people
- Sponsor
- Universidade Metodista de Piracicaba